欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
NL/H/4965/002
药品名称
Abiraterone 500 mg
活性成分
Abiraterone acetate 250.0 mg
剂型
Tablet
上市许可持有人
GL Pharma GmbH
参考成员国 - 产品名称
Netherlands (NL)
Abiralan 500 mg filmomhulde tabletten
互认成员国 - 产品名称
Romania (RO)
Slovakia (SK)
Abiraterone G.L. Pharma 500 mg filmom obalené tablety
Austria (AT)
Abirateron G.L. 500 mg-Filmtabletten
Poland (PL)
Abiralan
Latvia (LV)
Abiraterone G.L. Pharma 500 mg apvalkotās tabletes
Lithuania (LT)
Abiraterone G.L. Pharma 500 mg plėvele dengtos tabletės
Estonia (EE)
ABIRATERONE G.L. PHARMA
Hungary (HU)
许可日期
2021/03/10
最近更新日期
2024/11/22
药物ATC编码
L02BX03 abiraterone
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
PubAR
|
PAR_4965_Abirateron G_L__4 aug
Date of last change:2024/09/06
PubAR Summary
|
summaryPAR_4965_Abirateron G_L__4 aug_EN
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase